| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $66.4M | -18.0% |
| Cost of Revenue | $20.6M | -22.2% |
| Gross Profit | $45.8M | -16.0% |
| R&D Expense | $1.3M | -52.5% |
| SG&A Expense | $17.4M | -22.8% |
| Operating Income | -$7.8M | -49.0% |
| Pre-tax Income | -$13.7M | +2.4% |
| Income Tax | $437K | -75.3% |
| Net Income | -$13.6M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.0M | +54.7% |
| Accounts Receivable | $31.2M | +31.9% |
| Inventory | $11.4M | -9.5% |
| Current Assets | $79.2M | +27.9% |
| Total Assets | $124.2M | +5.2% |
| Current Liabilities | $63.1M | +1.3% |
| Long-term Debt | $10.9M | +0.2% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.9M | -39.6% |
| Capital Expenditures | $228K | -30.7% |
| Investing Cash Flow | -$2.6M | -678.1% |
| Financing Cash Flow | $15.4M | +1323.7% |
| Free Cash Flow | -$2.2M | -26.1% |
| +14.4% |
| EPS (Basic) | -$2.16 | +24.5% |
| Stockholders' Equity |
| $19.0M |
| -31.6% |